Cytonics
Cytonics is a biotechnology company developing diagnostic assays focusing on musculoskeletal-related pain.
Business Model:
Revenue: $10.4M
Employees: 51-200
Industries / Tags:
Detailed Cytonics Information
Geographic Data
Address: 658 West Indiantown Rd
City: Jupiter
State: FL
Zip: 33458
Country: US
Financial Info
Stage:
series c
Raised Last:
$0
Raised Total:$6M
Social
Metrics
735,033Website Global Rank
38,108Website Monthly Traffic
Twitter Followers
Description
Cytonics Corporation, a biotechnology company, develops diagnostic assays focusing on musculoskeletal related pain. It offers Fibronectin Aggrecan Complex Test (FACT) for molecular discography and FACT Plus multi analyte assay for diagnosing the source of pain in the spine and joints. Additionally, the company provides proteomics research and development services. Cytonics Corporation was founded in 2006 and is based in Jupiter, Florida.
Contact Phone:
+15614062864
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2012 | Grant | 1 | $1.6M |
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) |
5/2019 | Series C | 1 | - |
SeedInvest SeedInvest |
9/2018 | Convertible Note | $794k | 3/2011 | Venture Round | $1M | 5/2009 | Venture Round | $2.3M | 5/2019 | Seed Round | 1 | - |
Rainmakers Rainmakers |
5/2019 | Series C | 1 | - |
SeedInvest SeedInvest |
5/2019 | Seed Round | 1 | - |
Rainmakers Rainmakers |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
